Literature DB >> 24155308

Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model.

Hong Xie1, Jisong Guan, Laura A Borrelli, Jing Xu, Alberto Serrano-Pozo, Brian J Bacskai.   

Abstract

While accumulation of amyloid-β (Aβ) deposited as senile plaques is a hallmark feature of Alzheimer's disease (AD), the neurotoxicity of these deposits remains controversial. Recent in vitro studies suggested a link between elevated Aβ and mitochondrial dysfunction that might contribute to the pathogenesis of AD. However, the in vivo evidence for mitochondria dysfunction caused by Aβ is still missing. Using intravital multiphoton imaging with a range of fluorescent markers, we systematically surveyed mitochondrial structural and functional changes in AD mouse models. We observed severe impairments to be limited to the vicinity of Aβ plaques, which included reduction of both numbers and membrane potential of mitochondria and the emergence of dystrophic and fragmented mitochondria. Both neuronal soma and neurites with oxidative stress show severe alterations in mitochondrial membrane potential in amyloid precursor protein mice. These results provide in vivo evidence revealing Aβ plaques as focal sources of toxicity that lead to severe structural and functional abnormalities in mitochondria. These alterations may contribute to neuronal network dysfunction and warrant further investigation as possible targets for therapeutic intervention in AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155308      PMCID: PMC3807029          DOI: 10.1523/JNEUROSCI.1836-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase.

Authors:  Andrey Y Abramov; Laura Canevari; Michael R Duchen
Journal:  J Neurosci       Date:  2004-01-14       Impact factor: 6.167

3.  Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators.

Authors:  Colette T Dooley; Timothy M Dore; George T Hanson; W Coyt Jackson; S James Remington; Roger Y Tsien
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

4.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

5.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

Authors:  Marcus J Calkins; Maria Manczak; Peizhong Mao; Ulziibat Shirendeb; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-08-25       Impact factor: 6.150

6.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

7.  Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues.

Authors:  W Pendergrass; N Wolf; M Poot
Journal:  Cytometry A       Date:  2004-10       Impact factor: 4.355

8.  Rapid cell death is preceded by amyloid plaque-mediated oxidative stress.

Authors:  Hong Xie; Steven Hou; Jun Jiang; Maria Sekutowicz; Jonathan Kelly; Brian J Bacskai
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

9.  Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.

Authors:  Esther Pérez-Gracia; Benjamín Torrejón-Escribano; Isidre Ferrer
Journal:  Acta Neuropathol       Date:  2008-07-16       Impact factor: 17.088

10.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

View more
  80 in total

1.  Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation.

Authors:  Katarzyna Marta Zoltowska; Masato Maesako; Oksana Berezovska
Journal:  Mol Med       Date:  2016-07-05       Impact factor: 6.354

2.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

3.  Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.

Authors:  Diego Mastroeni; Omar M Khdour; Pablo M Arce; Sidney M Hecht; Paul D Coleman
Journal:  ACS Chem Neurosci       Date:  2015-02-24       Impact factor: 4.418

4.  Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance.

Authors:  Sinsuk Han; Yu Young Jeong; Preethi Sheshadri; Xiao Su; Qian Cai
Journal:  EMBO Rep       Date:  2020-07-06       Impact factor: 8.807

5.  Effect of AmyTrap, an amyloid-β binding drug, on Aβ induced mitochondrial dysfunction and tau phosphorylation in cultured neuroblastoma cells.

Authors:  Omkar Gandbhir; Pazhani Sundaram
Journal:  Metab Brain Dis       Date:  2020-05-04       Impact factor: 3.584

Review 6.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

7.  Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a 13C NMR metabolomic study.

Authors:  Qi Zhou; Hong Zheng; Jiuxia Chen; Chen Li; Yao Du; Huanhuan Xia; Hongchang Gao
Journal:  Metab Brain Dis       Date:  2018-06-26       Impact factor: 3.584

8.  Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.

Authors:  Dominic D Quintana; Jorge A Garcia; Yamini Anantula; Stephanie L Rellick; Elizabeth B Engler-Chiurazzi; Saumyendra N Sarkar; Candice M Brown; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 9.  In vivo functions of Drp1: lessons learned from yeast genetics and mouse knockouts.

Authors:  Hiromi Sesaki; Yoshihiro Adachi; Yusuke Kageyama; Kie Itoh; Miho Iijima
Journal:  Biochim Biophys Acta       Date:  2013-12-08

10.  Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Du Fang; Russell Howard Swerdlow; Haiyang Yu; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.